195 related articles for article (PubMed ID: 17229665)
21. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
[TBL] [Abstract][Full Text] [Related]
22. Posttraumatic parathyroid crisis and severe hypercalcemia treated with intravenous bisphosphonate (APD). Case report.
Canivet JL; Damas P; Lamy M
Acta Anaesthesiol Belg; 1990; 41(1):47-50. PubMed ID: 2360392
[TBL] [Abstract][Full Text] [Related]
23. [Tumor-induced hypercalcemia. Review of bisphosphonate treatment].
Lortholary A
Rev Med Interne; 2001 Jul; 22(7):648-52. PubMed ID: 11508158
[TBL] [Abstract][Full Text] [Related]
24. Undifferentiated pancreatic cancer associated with humoral hypercalcemia of malignancy.
Kakizaki S; Ohya N; Yoshinaga T; Higuchi T; Kitazawa R; Takayama H; Takagi H; Nagamine T; Mori M
Jpn J Clin Oncol; 1998 Sep; 28(9):563-6. PubMed ID: 9793031
[TBL] [Abstract][Full Text] [Related]
25. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
26. Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.
Harinck HI; Bijvoet OL; Plantingh AS; Body JJ; Elte JW; Sleeboom HP; Wildiers J; Neijt JP
Am J Med; 1987 Jun; 82(6):1133-42. PubMed ID: 3300303
[TBL] [Abstract][Full Text] [Related]
27. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
28. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
Blind E; Raue F; Meinel T; Wüster C; Ziegler R
Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
[TBL] [Abstract][Full Text] [Related]
29. Tumor-induced hypercalcemia in a patient with extensive soft tissue sarcoma: effects of bisphosphonate therapy and surgery.
Oleffe V; Dumon JC; Body JJ
J Surg Oncol; 1996 Oct; 63(2):125-9. PubMed ID: 8888806
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia secondary to gastrointestinal stromal tumors: parathyroid hormone-related protein independent mechanism?
Jasti P; Lakhani VT; Woodworth A; Dahir KM
Endocr Pract; 2013; 19(6):e158-62. PubMed ID: 24013983
[TBL] [Abstract][Full Text] [Related]
31. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
32. The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.
Adami S; Bolzicco GP; Rizzo A; Salvagno G; Bertoldo F; Rossini M; Suppi R; Lo Cascio V
Bone Miner; 1987 Aug; 2(5):395-404. PubMed ID: 2975514
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein.
Michigami T; Yamato H; Mushiake S; Nakayama M; Yoneda A; Satomura K; Imura K; Ozono K
J Clin Endocrinol Metab; 1996 Mar; 81(3):1090-5. PubMed ID: 8772581
[TBL] [Abstract][Full Text] [Related]
34. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
35. [Acute lymphoblastic leukemia accompanied by severe hypercalcemia; successful treatment with bisphosphonate].
Ogihara T; Kikuchi Y; Imai Y; Ohsaka A; Isaka M; Oka Y
Rinsho Ketsueki; 1995 Jan; 36(1):29-34. PubMed ID: 7715075
[TBL] [Abstract][Full Text] [Related]
36. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia of malignancy.
Body JJ
Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
39. [Hypercalcemia].
Matikainen N
Duodecim; 2014; 130(14):1404-12. PubMed ID: 25158579
[TBL] [Abstract][Full Text] [Related]
40. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]